艾伯维（纽约证券交易所代码：ABBV）报告称，公司季度每股收益为$2.16，超出分析师一致预期的$2.11，超出2.37%。这比去年同期的每股收益$2.79下降了22.58%。公司季度销售额为$151.02亿，超出分析师一致预期的$148.27亿，超出1.85%。这比去年同期的销售额$143.01亿增长了5.60%。
以上内容来自Benzinga Earnings专栏，原文如下：
AbbVie (NYSE:ABBV) reported quarterly earnings of $2.16 per share which beat the analyst consensus estimate of $2.11 by 2.37 percent. This is a 22.58 percent decrease over earnings of $2.79 per share from the same period last year. The company reported quarterly sales of $15.102 billion which beat the analyst consensus estimate of $14.827 billion by 1.85 percent. This is a 5.60 percent increase over sales of $14.301 billion the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.